Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Sleep Disorders
Mood Disorders
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Company News
Clinical & Scientific Network
Careers & Life at Cogstate
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Sleep Disorders
Mood Disorders
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Company News
Clinical & Scientific Network
Careers & Life at Cogstate
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Latest News
Find updates from Cogstate, leaders in the measurement of cognition.
Search
Show All
November 6, 2024
Cogstate Further Bolsters Alzheimer’s Disease Expertise, Welcoming Dr. Annamarie Vogt as Associate Vice President, AD Study Design and Endpoint Quality
October 29, 2024
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with eCOA and Clinician Solutions Powered by AI and Advanced Analytics
October 14, 2024
Cogstate Expands Alzheimer’s Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
January 30, 2024
Cogstate Announces Scientific Leadership Updates
June 20, 2022
Cogstate Joins New Collaborative of Global Healthcare Leaders to Define Core Digital Measures for Alzheimer’s Disease
June 14, 2022
Cogstate Announces Formation of Scientific Advisory Board
May 20, 2022
Clario and Cogstate Expand Partnership to Deliver Leading Data Collection and Data Quality Programs for Clinical Trials
January 12, 2022
Eisai to Launch Digital Tool “CogMate™ in Taiwan And Hong Kong
November 30, 2021
Cogstate Technology to be Installed on Japanese Smartphone Targeting Senior Population
November 29, 2021
Clinical Trial in Dementia with Lewy Bodies Used Cogstate Digital Assessments and Data Quality Services to Support the Evaluation of Neflamapimod
We use cookies to analyze our website traffic and to support technical features that enhance your user experience. Read our
Privacy
and
Cookie
Policies to learn more about how we use cookies.
Accept Cookies
Decline Cookies